首页> 外文期刊>Gastrointestinal Endoscopy >Early additional endoscopic submucosal dissection in patients with positive lateral resection margins after initial endoscopic submucosal dissection for early gastric cancer
【24h】

Early additional endoscopic submucosal dissection in patients with positive lateral resection margins after initial endoscopic submucosal dissection for early gastric cancer

机译:初次胃癌内镜下黏膜下剥离术后外侧切缘阳性的患者的早期额外内镜下黏膜下剥离术

获取原文
获取原文并翻译 | 示例
           

摘要

Endoscopic submucosal dissection (ESD) has become the standard treatment for early gastric cancer (EGC). Compared with EMR, ESD resects larger tumors en bloc, thereby permitting more precise pathologic assessment compared with piecemeal EMR. These features serve to justify the expanded use of ESD in patients with EGCs without clinical evidence of lymph node metastasis. Approximately 5% to 10% of patients undergoing ESD have incomplete resections, as follows: the presence of tumor in the resection margin and deep submucosal or lymphovascular invasion in the resected specimen. In these cases, gastrectomy has usually been performed for secondary treatment. Given the complications and consequent decrease in quality of life after surgery and recent advances in the ESD technique, early additional ESD may be another treatment option. There have been no reports of the usefulness of early additional ESD.
机译:内镜黏膜下剥离术(ESD)已成为早期胃癌(EGC)的标准治疗方法。与EMR相比,ESD可整块切除更大的肿瘤,因此与零碎EMR相比,可以进行更精确的病理评估。这些特征可证明在没有淋巴结转移的临床证据的情况下,在患有EGC的患者中广泛使用ESD是合理的。大约5%至10%的接受ESD的患者具有不完全切除的情况,如下所示:切除边缘存在肿瘤,切除标本中存在深层粘膜下或淋巴血管浸润。在这些情况下,胃切除术通常已经进行了二级治疗。鉴于手术后的并发症和随之而来的生活质量下降以及ESD技术的最新进展,早期额外的ESD可能是另一种治疗选择。尚无关于早期增加ESD有用性的报道。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号